Bar JK - Search Results

1

Cytogenetic and molecular cytogenetic characterization of the stable ovarian carcinoma cell line (OvBH-1).

Schlade-Bartusiak K, Sasiadek MM, Bar JK, Urbschat S, Blin N, Montenarh M, Harłozińska-Szmyrka A. Schlade-Bartusiak K, et al. Among authors: bar jk. Cancer Genet Cytogenet. 2006 Jan 1;164(1):10-5. doi: 10.1016/j.cancergencyto.2005.04.011. Cancer Genet Cytogenet. 2006. PMID: 16364757

2

p53 autoantibodies in the sera, cyst and ascitic fluids of patients with ovarian cancer.

Montenarh M, Harloziñska A, Bar JK, Kartarius S, Günther J, Sedlaczek P. Montenarh M, et al. Among authors: bar jk. Int J Oncol. 1998 Sep;13(3):605-10. doi: 10.3892/ijo.13.3.605. Int J Oncol. 1998. PMID: 9683801

3

Analysis of the immunoreactivity of three anti-p53 antibodies and estimation of the relations between p53 status and MDM2 protein expression in ovarian carcinomas.

Harlozińska A, Bar J, Montenarh M. Harlozińska A, et al. Anticancer Res. 2000 Mar-Apr;20(2A):1049-56. Anticancer Res. 2000. PMID: 10810396

4

Morphological and phenotypic characterization of a new established ovarian carcinoma cell line (OvBH-1).

Bar JK, Harlozińska A. Bar JK, et al. Anticancer Res. 2000 Sep-Oct;20(5A):2975-80. Anticancer Res. 2000. PMID: 11062710

5

Temperature-sensitive ovarian carcinoma cell line (OvBH-1).

Bar JK, Harlozinska A, Kartarius S, Montenarh M, Wyrodek E, Parkitna JM, Kochman M, Ozyhar A. Bar JK, et al. Jpn J Cancer Res. 2002 Sep;93(9):976-85. doi: 10.1111/j.1349-7006.2002.tb02473.x. Jpn J Cancer Res. 2002. PMID: 12359050 Free PMC article.

6

Relations between immunologically different p53 forms, p21(WAF1) and PCNA expression in ovarian carcinomas.

Harlozinska A, Bar JK, Montenarh M, Kartarius S. Harlozinska A, et al. Among authors: bar jk. Oncol Rep. 2002 Nov-Dec;9(6):1173-9. Oncol Rep. 2002. PMID: 12375014

7

Combination of therapy with 5-fluorouracil and cisplatin with electroporation in human ovarian carcinoma model in vitro.

Saczko J, Kamińska I, Kotulska M, Bar J, Choromańska A, Rembiałkowska N, Bieżuńska-Kusiak K, Rossowska J, Nowakowska D, Kulbacka J. Saczko J, et al. Biomed Pharmacother. 2014 Jun;68(5):573-80. doi: 10.1016/j.biopha.2014.05.005. Epub 2014 Jun 12. Biomed Pharmacother. 2014. PMID: 24975085

8

Oxidative modification induced by photodynamic therapy with Photofrin®II and 2-methoxyestradiol in human ovarian clear carcinoma (OvBH-1) and human breast adenocarcinoma (MCF-7) cells.

Saczko J, Choromańska A, Rembiałkowska N, Dubińska-Magiera M, Bednarz-Misa I, Bar J, Marcinkowska A, Kulbacka J. Saczko J, et al. Biomed Pharmacother. 2015 Apr;71:30-6. doi: 10.1016/j.biopha.2015.02.008. Epub 2015 Feb 19. Biomed Pharmacother. 2015. PMID: 25960212

9

Comparative Analysis of Primary Ovarian Cancer Cells and Established Cell Lines as a New Tool for Studies on Ovarian Cancer Cell Complexity.

Szyposzynska A, Bielawska-Pohl A, Paprocka M, Bar J, Murawski M, Klimczak A. Szyposzynska A, et al. Int J Mol Sci. 2024 May 15;25(10):5384. doi: 10.3390/ijms25105384. Int J Mol Sci. 2024. PMID: 38791431 Free PMC article.

10

Comparison of cellular phenotypes in tumor cyst and ascitic fluid from ovarian serous carcinoma.

Harlozinska A, Bar JK, Richter R, Cislo M. Harlozinska A, et al. Among authors: bar jk. Acta Cytol. 1992 Nov-Dec;36(6):869-74. Acta Cytol. 1992. PMID: 1449024

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters